These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10963939)

  • 21. Characterization of a pentylenetetrazol-like interoceptive stimulus produced by ethanol withdrawal.
    Lal H; Harris CM; Benjamin D; Springfield AC; Bhadra S; Emmett-Oglesby MW
    J Pharmacol Exp Ther; 1988 Nov; 247(2):508-18. PubMed ID: 3183950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abecarnil, a new beta-carboline, in the treatment of anxiety disorders.
    Aufdembrinke B
    Br J Psychiatry Suppl; 1998; (34):55-63. PubMed ID: 9829018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the mGluR5 antagonist MPEP on ethanol withdrawal induced anxiety-like syndrome in rats.
    Kumar J; Hapidin H; Bee YT; Ismail Z
    Behav Brain Funct; 2013 Nov; 9():43. PubMed ID: 24279870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-blind comparison of abecarnil and diazepam in the treatment of uncomplicated alcohol withdrawal.
    Anton RF; Kranzler HR; McEvoy JP; Moak DH; Bianca R
    Psychopharmacology (Berl); 1997 May; 131(2):123-9. PubMed ID: 9201799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitization to 5-HT1C receptor agonist in rats observed following withdrawal from chronic ethanol.
    Rezazadeh SM; Prather PL; Lal H
    Alcohol; 1993; 10(4):281-3. PubMed ID: 8397879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dansyl-PQRamide, a putative antagonist of NPFF receptors, reduces anxiety-like behavior of ethanol withdrawal in a plus-maze test in rats.
    Kotlinska J; Pachuta A; Bochenski M; Silberring J
    Peptides; 2009 Jun; 30(6):1165-72. PubMed ID: 19463751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enkephalin analog, cyclo[N(ε),N(β)-carbonyl-D-Lys(2),Dap(5)] enkephalinamide (cUENK6), inhibits the ethanol withdrawal-induced anxiety-like behavior in rats.
    Gibula-Bruzda E; Marszalek-Grabska M; Witkowska E; Izdebski J; Kotlinska JH
    Alcohol; 2015 May; 49(3):229-36. PubMed ID: 25716198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential role of 5HT1C and/or 5HT2 receptors in the mianserin-induced prevention of anxiogenic behaviors occurring during ethanol withdrawal.
    Lal H; Prather PL; Rezazadeh SM
    Alcohol Clin Exp Res; 1993 Apr; 17(2):411-7. PubMed ID: 8488986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucagon-like peptide-1 (GLP-1) receptor agonist prevents development of tolerance to anti-anxiety effect of ethanol and withdrawal-induced anxiety in rats.
    Sharma AN; Pise A; Sharma JN; Shukla P
    Metab Brain Dis; 2015 Jun; 30(3):719-30. PubMed ID: 25380665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of several benzodiazepine receptor ligands in two models of anxiolytic activity in the mouse: an analysis based on fractional receptor occupancies.
    Jones GH; Schneider C; Schneider HH; Seidler J; Cole BJ; Stephens DN
    Psychopharmacology (Berl); 1994 Mar; 114(2):191-9. PubMed ID: 7838907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose- and time-dependent expression of anxiety-like behavior in the elevated plus-maze during withdrawal from acute and repeated intermittent ethanol intoxication in rats.
    Zhang Z; Morse AC; Koob GF; Schulteis G
    Alcohol Clin Exp Res; 2007 Nov; 31(11):1811-9. PubMed ID: 17877783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protracted withdrawal: sensitization of the anxiogenic response to cocaine in rats concurrently treated with ethanol.
    Prather PL; Lal H
    Neuropsychopharmacology; 1992 Jan; 6(1):23-9. PubMed ID: 1571066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alprazolam dependence prevented by substituting with the beta-carboline abecarnil.
    Pinna G; Galici R; Schneider HH; Stephens DN; Turski L
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2719-23. PubMed ID: 9122263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential role of the gene transcription factor cyclic AMP-responsive element binding protein in ethanol withdrawal-related anxiety.
    Pandey SC; Zhang D; Mittal N; Nayyar D
    J Pharmacol Exp Ther; 1999 Feb; 288(2):866-78. PubMed ID: 9918601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term treatment with abecarnil does not induce diazepam-like dependence in mice.
    Steppuhn KG; Schneider HH; Turski L; Stephens DN
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1395-400. PubMed ID: 8095551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic pharmacological activities of the novel anxiolytic beta-carboline abecarnil in rats.
    Ozawa M; Sugimachi K; Nakada-Kometani Y; Akai T; Yamaguchi M
    J Pharmacol Exp Ther; 1994 May; 269(2):457-62. PubMed ID: 7910208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of various glutamate receptors antagonists on anxiety-like effect of ethanol withdrawal in a plus-maze test in rats.
    Kotlinska J; Bochenski M
    Eur J Pharmacol; 2008 Nov; 598(1-3):57-63. PubMed ID: 18838071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term abecarnil administration produces tolerance and withdrawal signs in the rat.
    Elliot EE; White JM
    Eur J Pharmacol; 2000 Apr; 394(2-3):237-45. PubMed ID: 10771289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "Anxiolytic" action of diazepam and abecarnil in a modified open field test.
    Rex A; Stephens DN; Fink H
    Pharmacol Biochem Behav; 1996 Apr; 53(4):1005-11. PubMed ID: 8801571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased anxiety-like behavior and ethanol self-administration in dependent rats: reversal via corticotropin-releasing factor-2 receptor activation.
    Valdez GR; Sabino V; Koob GF
    Alcohol Clin Exp Res; 2004 Jun; 28(6):865-72. PubMed ID: 15201629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.